期刊論文| 1. | Hovenkamp, Herbert J.、Janis, Mark D.、Lemley, Mark A.(2003)。Anticompetitive Settlement of Intellectual Property Disputes。Minn. L. Rev.，87，1719-1766。   |
| 2. | Hovenkamp, Herbert(2014)。Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision。Minn. J. L. Sci. and Tech.，15，3+8。 |
| 3. | Ghosh, Shubha(2014)。Convergence?。Minn. J. L. SCI. and Tech.，15，95-96。 |
| 4. | Shapiro, Carl(2003)。Antitrust Limits to Patent Settlements。The Rand Journal of Economics，34(2)，391-411。 |
| 5. | 馮震宇(20120700)。藥品專利與競爭法之互動--從學名藥逆向付款爭議談起。專利師，10，98-125。 延伸查詢 |
| 6. | 張哲倫、李素華(20141100)。專利法之經濟結構--經濟分析理論對於臺灣專利制度運作之啟發。月旦法學，234，229-262。 延伸查詢 |
| 7. | Carrier, Michael A.(2014)。Payment After Actavis。Iowa Law Review，100(1)，7-49。 |
| 8. | Choi, William(2014)。Pay-'For'Delay Practices in the Pharmaceutical Sector: Lundbeck, Actavis, and Others。J. EUR. COMPETITION L. & PRAC.，5，44。 |
| 9. | Dickey, Bret(2010)。An Economic Assessment of Patent Settlements in the Pharmaceutical Industry。Annals Health L.，19，367。 |
| 10. | Lemley, Mark A.(2007)。A New Balance Between IP and Antitrust。Sw. J. L. & Trade Am.，13，237。 |
| 11. | Lewis, Jeffrey I. D.、Wittlin, Maggie(2015)。Entering the Innovation Twilight Zone: How Patent and Antitrust Law Must Work Together。VAND. J. Ent. & TECH. L.，17，517。 |
| 12. | Lim, Daryl(2014)。Patent Misuse and Antitrust: Rebirth or False Dawn?。MlCH. TELECOMM. & Tech. L. Rev.，20，299。 |
| 13. | Willig, Robert D.、Bigelow, John P.(2004)。Antitrust Policy Toward Agreements That Settle Patent Litigation。Antitrust Bull，49，655。 |
| 14. | Yu, Xiang、Chatterji, Anjan(2011)。Why Brand Pharmaceutical Companies Choose to Pay Generics in Settling Patent Disputes: A Systematic Evaluation of the Asymmetric Risks in Litigation。NW. J. Tech. & INTELL. PROP.，10，18。 |
| 15. | Fraile, Irene(2014)。Drug Test: When Are Pay-for-Delay Agreements Illegal?。GLOBAL Competition Litig. Rev.，4，214。 |
| 16. | 王立達(20091100)。美國競爭法近期發展與政權移轉之可能影響--避免過度嚇阻、重視經濟學理到強化執法。月旦法學，174，230-240。 延伸查詢 |
| 17. | 王立達(20080100)。限制競爭之專利侵害和解：尋求合適分析架構。全國律師，12(1)，51-62。 延伸查詢 |
| 18. | 王偉霖(20110100)。公平交易法限制事業發侵害智慧財產權警告信之實務與探討。全國律師，15(1)，27-40。 延伸查詢 |
| 19. | 熊誦梅(20081000)。不當行使專利權之法律效果及救濟途徑--從美國法上之專利地痞、專利濫用及智慧財產授權準則談起。全國律師，12(10)，56-67。 延伸查詢 |
| 20. | 王立達、陳蔚奇(20101200)。學名藥上市審查之專利連結制度：從美國經驗檢證其存立基礎與制度設計。國立臺灣大學法學論叢，39(4)，349-406。 延伸查詢 |
其他| 1. | 葉雲卿。淺談美國專利聯結制度系列學名藥180天市場專屬權之起源，http://www.naipo.com/Portals/l/web_tw/Knowledge_Center/Industry_Economy/publish-318.htm， 2015/11/07。 延伸查詢 |
| 2. | Botti, Mark J.(201306)。Redefining the Border Between Intellectual Property and Antitrust: Implications of FTC v. Actavis, Squire Patton Boggs，http://www.squirepattonboggs.com/~/media/files/insights/publications/2013/06/redefi.ning-the-border-between-intellectual-prope/files/redefiningtheborderbetweenintellectualpropertyan/fileattachment/redefmingtheborderbetweenintellectualpropertyan.pdf.。 |
| 3. | European Commission(20130619)。Antitrust: Commission Fines Lundbeck and Other Pharma Companies for Delaying Market Entry of Generic Medicines。 |
| 4. | Eur. Comm'n(20141205)。5th Report on the Monitoring of Patent Settlements (Jan.-Dec. 2013)，http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/patent_settlem ents_report5_en.pdf。 |
| 5. | Eur. Comm'n(20140625)。Guidance on Restrictions of Competition "By Object” for the Purpose of Defining Which Agreements May Benefit from the De Minimis Notice，http://ec.europa.eu/competition/antitrast/legislation/de_miiiimisjnotice_annex.pdf。 |
| 6. | (20140916)。"By Object" Restrictions of Competition Revisited: European Court of Justice Endorses Narrow Interpretation，http://www.lw.com/thoughtLeadership/LW-European-Justice-Court-Groupement-Cartes-Bancaires。 |
| 7. | Crouch, Dennis(20131125)。IP Law Professors Rise-Up Against Patent Assertion Entities, PATENTLY-O，http://patentlyo.com/patent/2013/11/ip-law-professors-rise-up-against-patent-assertion-entities.html。 |
| 8. | European Commission(20140709)。Antitrust: Commission Fines Servier and Five Generic Companies for Curbing Entry of Cheaper Versions of Cardiovascular Medicine。 |
| 9. | Lakdawalla, Darius，Philipson, Tomas。Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets，http://www.ncbi.nlm,nih.gov/pmc/articles/PMC4161291/， 2015/07/20。 |
| 10. | Pierce, Jennifer，Birch, Christopher(20140408)。UK: Reverse Payments in Patent Settlements--“Pay for Delay”?，http://www.mondaq.com/x/305206/Patent/Reverse+Payments+In+Patent+Settlements+Pay+For+Delay。 |
| 11. | Shadowen, Steve D.(201309)。Exclusion Payment Litigation: What's Next?，http://www.aipla.org/committees/committee_pages/antitrust-law/Committee%20Documents/Committee%20Programs/2013 %20Annual%20Meeting/Sh adowen%20paper.pdf。 |